Fifty years of rhesus-immunization immunoprophylaxis: on guard of perinatal morbidity and infant mortality

Savelyeva G.M., Kurtser M.A., Sichinava L.G., Konoplyannikov A.G., Latyshkevich O.A., Songolova E.N.

1 Pirogov Russian National Researcn Medical University, Moscow, Russia; 2 Center for Planning Family and Reproduction, Moscow Department of Health, Moscow, Russia; 3 Scientific Research Institute of Healthcare Organization and Medical Management, Moscow Department of Health, Moscow, Russia
The problem of prevention of hemolytic disease of the fetus and newborn among the indigenous population has been solved in economically developed countries due to the high organization of immunization. This issue is relevant to the present time in our country. The first clinical case of neonatal jaundice was described in 1609. The pathogenesis of the disease was determined three centuries later. American researchers obtained permission to use anti-rhesus gamma globulin in 1968. Since then it has been widely used abroad for both postpartum and antenatal prevention. Anti-rhesus immunoglobulin was introduced into clinical practice in our country thanks to the works of V.M. Sidelnikova. However, domestic drugs to date are not standardized in the micrograms. They can be used only after childbirth. We use foreign immunoglobulin during pregnancy. The cause of sensitization can be not only the lack of postnatal prevention, but also insufficient dose of the drug. To avoid this, we recommend implementing the Kleihauer-Betke method.

Keywords

Keyword: Rh-sensitization
hemolytic disease
anti-D immunoglobulins
RhD-prophylaxis
preimplantation genetic diagnosis

References

1. Айламазян Э.К., Павлова Н.Г. Изоиммунизация при беременности. СПб.: Н-Л; 2012. 164с. [Aylamazyan E.K., Pavlova N.G. Isoimmunization during pregnancy. SPb .: NH; 2012. 164p. (in Russian)]

2. Савельева Г.М., Коноплянников А.Г., Курцер М.А., Панина О.Б. Гемолитическая болезнь плода и новорожденного. М.: ГЭОТАР-Медиа; 2013. 144с. [Savelyeva G.M., Konoplyannikov A.G., Kurtser M.A., Panina O.B. Hemolytic disease of the fetus and newborn. M .: GEOTAR-Media; 2013. 144p. (in Russian)]

3. Мамедалиева Н.М., Шарипбаева Н.Т., Данияров Н.Н., Джиджилава Г.М. Особенности течения беременности, родов и перинатальные исходы у пациенток с резус-сенсибилизацией. Вестник КазНМУ. 2015; 1: 18-21. [Mamedalieva N.M., Sharipbaeva N.T., Daniyarov N.N., Djidzhilava G.M. Features of the course of pregnancy, childbirth and perinatal outcomes in patients with Rh sensitization. Bulletin of KazNMU. 2015; 1: 18-21. (in Russian)]

4. Шейбак Л.Н. Современные представления об особенностях гемолитической болезни плода и новорожденного. Журнал Гродненского государственного медицинского университета. 2015; 1: 134-8. [Sheibak L.N. Modern ideas about the features of hemolytic disease of the fetus and newborn. Journal of Grodno State Medical University. 2015; 1: 134-8. (in Russian)]

5. Абдрахманова Л.Р., Токтарова О.А., Ситарская М.В., Мусина Д.М. Анализ результатов ультразвукового допплерометрического исследования — кровотока в средней мозговой артерии у плода при резус-иммунизации. Практическая медицина. 2015; 4: 7-9. [Abdrakhmanova L.R., Toktarova O.A., Sitarskaya M.V., Musina D.M. Analysis of the results of Doppler ultrasound study - blood flow in the middle cerebral artery of the fetus during Rh immunization. Practical medicine. 2015; 4: 7-9. (in Russian)]

6. Иванова А.В., Захарова С.Ю., Косовцова Н.В., Павличенко М.В., Генералов А.Е. Особенности течения неонатального периода у новорожденных, получивших внутриутробное внутрисосудистое переливание крови по поводу гемолитической болезни плода. Российский вестник перинатологии и педиатрии. 2015; 1: 44-8. [Ivanova A.V., Zakharova S.Yu., Kosovtsova N.V., Pavlichenko M.V., Generalov A.E. Features of the neonatal period in newborns who received intrauterine intravascular blood transfusion for hemolytic disease of the fetus. Russian Bulletin of Perinatology and Pediatrics. 2015; 1: 44-8. (in Russian)]

7. Иванова А.В., Захарова С.Ю., Пестряева Л.А. Особенности морфологии эритроцитов у детей с гемолитической болезнью новорожденных, перенесших внутриутробное внутрисосудистое переливание крови. Российский вестник перинатологии и педиатрии. 2016; 1: 42-5. [Ivanova A.V., Zakharova S.Yu.,Pestryaeva L.A. Features of the erythrocyte morphology in children with hemolytic disease of newborns who have undergone intrauterine intravascular blood transfusion. Russian Bulletin of Perinatology and Pediatrics. 2016; 1: 42-5. (in Russian)]

8. Кравченко Е.Н., Ожерельева М.А., Куклина Л.В., Кропмаер К.П., Цыганкова О.Ю. Совершенствование алгоритма ведения беременных с резусиммунизацией: диагностические аспекты. Мать и дитя в Кузбассе. 2017; 4: 43-7. [Kravchenko E.N., Ozhereleva M.A., Kuklina L.V., Kropmaer K.P., Tsygankova O.Yu. Improving the algorithm for managing pregnant women with Rhesus immunization: diagnostic aspects. Mother and child in Kuzbass. 2017; 4: 43-7. (in Russian)]

9. McCauley C.J., Morris K., Maguire K. A review of maternal alloimmunisation to Rh D in Northern Ireland. Transfus. Med. 2017; 27(2): 132-5. doi: 10.1111/tme.12387.

10. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No.181: prevention of Rh D alloimmunization. Obstet. Gynecol. 2017; 130(2): e57-70. doi: 10.1097/AOG.0000000000002232.

11. Fung K.F.K., Eason E. No.133-prevention of Rh alloimmunization. J. Obstet. Gynaecol. Can. 2018; 40(1): e1-10. doi: 10.1016/j.jogc.2017.11.007.

12. Fasano R.M. Hemolytic disease of the fetus and newborn in the molecular era. Semin. Fetal Neonatal Med. 2016; 21(1): 28-34. doi: 10.1016/j.siny.2015.10.006.

13. Beserra A.H., Artmann E., Santos M.C. RhD alloimmunization in pregnant women in Rio de Janeiro State, Brazil: perspectives and challenges. Cad. Saude Publica. 2016; 32(11): e00005516. doi: 10.1590/0102-311X00005516.

14. Zonneveld R., Kanhai H.H., Lamers M., Brand A., Zijlmans W.R., Schonewille H. D. antibodies in pregnant women in multiethnic Suriname: the observational RheSuN study. Transfusion. 2017; 57(10): 2490-5. doi: 10.1111/trf.14235.

15. Díaz-Solano D., Fuenmayor J., Montaño R.F. Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies. Blood Transfus. 2018; 16(2): 200-8. doi: 10.2450/2017.0176-16.

16. Курцер М.А., Коноплянников А.Г. Профилактика гемолитической болезни. Вестник РГМУ. 2008; 6: 43-7. [Kurtser M.A., Konoplyannikov A.G. Prevention of hemolytic disease. Bulletin of Russian State Medical University. 2008; 6: 43-7. (in Russian)]

17. Белуга М.В. Резус-конфликт: прошлое и настоящее в решении проблемы. Журнал Гродненского государственного медицинского университета. 2012; 1: 24-9. [Beluga M.V. Rhesus conflict: past and present in solving the problem. Journal of Grodno State Medical University. 2012; 1: 24-9. (in Russian)]

18. Bowman J. Rh-immunoglobulin: Rh prophylaxis. Best Pract. Res. Clin. Haematol. 2006; 19(1): 27-34.

19. Hansen T.W. Pioneers in the scientific study of neonatal jaundice and kernicterus. Pediatrics. 2000; 106(2): E15.

20. Таболин В.А. Билирубиновый обмен и желтухи новорожденных. М.: Медицина; 1967. 228с. [Tabolin V.A. Bilirubin metabolism and jaundice of newborns. M .: Medicine; 1967. 228p. (in Russian)]

21. Landsteiner K., Wiener A.S. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc. Soc. Exp. Biol. Med. 1940; 43: 223-5.

22. Levine P., Stetson P. An unusual case of intragroup agglutination. JAMA. 1939; 113: 126-7.

23. Kleihauer E., Braun H., Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin. Wochenschr. 1957; 12(35): 637-8.

24. Clarke C.A. Prevention of Rhesus isoimmunization. Lancet. 1968; 2(7558): 1-7.

25. Freda V., Gorman J., Pollack W. Successful prevention of experimental Rh-sensitization preliminary report. Transfusion (Philad.). 1964; 4: 26-32.

26. Сидельникова В.М., Антонов А.Г. Гемолитическая болезнь плода и новорожденного. М.: Триада-X; 2004. 191с. [Sidelnikova V.M., Antonov A.G. Hemolytic disease of the fetus and newborn. M .: Triad-X; 2004. 191p.(in Russian)]

27. Сидельников В.М. Особенности кислородного насыщения крови плода при резус-конфликте. В кн.: Материалы научно-практической конференции «Вопросы физиологии и патологии плода и новорожденного». М.; 1966: 13-4. [Sidelnikov V.M. Features of the oxygen saturation of the blood of the fetus during Rh-conflict. In the book: Materials of the scientific-practical conference “Issues of physiology and pathology of the fetus and newborn.” M .; 1966: 13-4. (in Russian)]

28. Сидельникова В.М. Антенатальная диагностика, лечение гемолитической болезни плода при резус-сенсибилизации и меры ее профилактики. Акушерство и гинекология. 2005; 5: 56-60. [Sidelnikova V.M. Antenatal diagnosis, treatment of hemolytic disease of the fetus with Rh sensitization and measures for its prevention. Obstetrics and gynecology. 2005; 5: 56-60. (in Russian)]

29. Bernardo L., Yu H., Amash A., Zimring J.C., Lazarus A.H. IgG-mediated immune suppression to erythrocytes by polyclonal antibodies can occur in the absence of activating or inhibitory Fcγ receptors in a full mouse model. J. Immunol. 2015; 195(5): 2224-30. doi: 10.4049/jimmunol.1500790.

30. Распоряжение Правительства Москвы от 05.09.2008 года № 2028-РП «О внесении изменений в распоряжение Правительства Москвы от 10.08.2005 №1506-РП». Available at: http://mosopen.ru/document/2028_rp_2008-09-05 [Order of the Government of Moscow of September 5, 2008 No. 2028-RP “On Amendments to the Order of the Government of Moscow from August 10, 2005 №1506-РП ". Available at: http://mosopen.ru/document/2028_rp_2008-09-05 (in Russian)]

31. Приказ Департамента здравоохранения г. Москвы от 06.10.2008 года №748 «О лекарственном обеспечении беременных женщин». Available at: http://rudoctor.net/medicine2009/bz-gw/med-qmnau.htm [Order of the Moscow Department of Health dated October 6, 2008 № 748 "On the provision of medicines for pregnant women." Available at: http://rudoctor.net/medicine2009/bz-gw/med-qmnau.htm (in Russian)]

32. Приказ Министерства здравоохранения РФ № 572н от 1.11.2012 «Об утверждении порядка оказания медицинской помощи по профилю «акушерство и гинекология» (за исключением использования вспомогательных репродуктивных технологий)». Available at: http://base.garant.ru/70352632/. [Order of the Ministry of Health of the Russian Federation No. 572n of November 1, 2012 “On approval of the procedure for providing medical care in the profile of wool and gynecology "(with the exception of the use of auxiliary reproductive technologies) ". Available at: http: //base.garant.ru/70352632/. (in Russian)]

33. Клинический протокол Министерства здравоохранения РФ от 18 мая 2017 г. N 15-4/10/2-330. О направлении клинических рекомендаций (протокола) «Резус-сенсибилизация. Гемолитическая болезнь плода». Available at: http://docs.cntd.ru/document/456085287 [Clinical Protocol of the Ministry of Health of the Russian Federation of May 18 2017 N 15-4/10/2-330. About the direction of clinical guidelines (protocol) "Rhesus sensitization. Hemolytic disease of the fetus. Available at: http://docs.cntd.ru/document/456085287 (in Russian)]

34. Нерсисян В.М., Маркарян П.А., Акопян Л.П. Определение резус-принадлежности плода в крови беременных. Журнал экспериментальной и клинической медицины. 1974; 5: 17-23. [Nersisyan V.M., Markaryan P.A., Akopyan L.P. Definition of Rh-accessories of the fetus in the blood of pregnant women. Journal of Experimental and Clinical Medicine. 1974; 5: 17-23. (in Russian)]

35. Shen R., Sandler S.G. Transfusion medicine illustrated. Miscounting even one lymphocyte in the Kleihauer-Betke (acid-elution) assay can result in overdosing Rh immune globulin. Transfusion. 2015; 55(9): 2069. doi: 10.1111/trf.13056.

36. Girard M., Marchand F., Uch R., Bretelle F. Trauma and pregnancy: Is the Kleihauer-Betke test really useful? Gynecol. Obstet. Fertil. Senol. 2017; 45(11): 584-9. doi: 10.1016/j.gofs.2017.08.009.

37. Lebrun B., Jacquemyn Y. Usefulness of maternal fetal red blood cell count in rhesus-positive pregnant women. Horm. Mol. Biol. Clin. Investig. 2018; 35(3): pii: /j/hmbci.2018.35.issue-3/hmbci-2018-0028/hmbci-2018-0028.xml. doi: 10.1515/hmbci-2018-0028.

38. Spychalska J., Uhrynowska M., Pyl H., Klimczak-Jajor E., Kopeć I., Peciakowska M. et al. Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women. Ginekol. Pol. 2015; 86(7): 486-93.

39. Seeho S.K., Burton G., Leigh D., Marshall J.T., Persson J.W., Morris J.M. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report. Hum. Reprod. 2005; 20(3): 697-701.

40. Mattaloni S.M., Arnoni C., Céspedes R., Nonaka C., Trucco Boggione C., Luján Brajovich M.E. et al. Clinical significance of an alloantibody against the Kell Blood Group Glycoprotein. Transfus. Med. Hemother. 2017; 44(1): 53-7. doi: 10.1159/000448381.

Received 30.11.2018

Accepted 07.12.2018

About the Authors

Savelyeva, Galina M., MD, professor, academician of the Russian Academy of Sciences, Department of Obstetrics and Gynecology, Russian National Research Medical University named after N.I. Pirogov. 117997, Russia, Moscow, Ostrovityanova str. 1. Tel.:+74957183472. E-mail: gms@cfp.ru
Kurtser, Mark A., MD, professor, academician of the Russian Academy of Sciences, head of Department of Obstetrics and Gynecology, Russian National Research Medical University named after N.I. Pirogov. 117997, Russia, Moscow, Ostrovityanova str. 1. Tel.:+74957183472. E-mail: agpf-gms@gmail.com
Sichinava, Lali G., MD, professor, Department of Obstetrics and Gynecology, Russian National Research Medical University named after N.I. Pirogov.
117997, Russia, Moscow, Ostrovityanova str. 1. Tel.:+74957183472. E-mail: agpf-gms@gmail.com
Konoplyannikov, Aleksandr G., MD, professor, Department of Obstetrics and Gynecology, Russian National Research Medical University named after N.I. Pirogov.
117997, Russia, Moscow, Ostrovityanova str. 1. Tel.:+74997230420. E-mail: npo.med@gmail.com
Latyshkevich, Oleg A., PhD, assistant, Department of Obstetrics and Gynecology, Russian National Research Medical University named after N.I. Pirogov.
117997, Russia, Moscow, Ostrovityanova str. 1 Tel.:+74957183472. E-mail: agpf-gms@gmail.com.
Chief doctor of Family planning and human reproduction center affiliated Moscow city Department of Health.
117209, Russia, Moscow, Sevastopolskiy pr. 24 A. Tel.:+4957182070. E-mail: cpsr@zdrav.mos.ru
Songolova, Ekaterina N., PhD, head of Division of Obstetrics and Gynecology, Scientific Research Institute of Healthcare Organization and medical Management.
115088, Russia, Moscow, Sharikopodshipnikovskaya str. 9. Tel.:+74956134119. E-mail: songolovaEN@zdrav.mos.ru

For citations: Savelyeva G.M., Kurtser M.A., Sichinava L.G., Konoplyannikov A.G., Latyshkevich O.A., Songolova E.N. Fifty years of rhesus-immunization immunoprophylaxis: on guard of perinatal morbidity and infant mortality (historical review). Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (12): 177-83. (in Russian)
http://dx.doi.org/10.18565/aig.2018.12.177-183

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.